---
reference_id: "PMID:35235819"
title: Management of Cardiac Symptoms in Amyloidosis.
authors:
- King P
- Kates AM
journal: Am J Med
year: '2022'
doi: 10.1016/j.amjmed.2022.02.005
content_type: abstract_only
---

# Management of Cardiac Symptoms in Amyloidosis.
**Authors:** King P, Kates AM
**Journal:** Am J Med (2022)
**DOI:** [10.1016/j.amjmed.2022.02.005](https://doi.org/10.1016/j.amjmed.2022.02.005)

## Content

1. Am J Med. 2022 Apr;135 Suppl 1:S9-S12. doi: 10.1016/j.amjmed.2022.02.005. Epub
 2022 Feb 27.

Management of Cardiac Symptoms in Amyloidosis.

King P(1), Kates AM(2).

Author information:
(1)Cardiovascular Division, Washington University School of Medicine, St. Louis, 
Mo.
(2)Cardiovascular Division, Washington University School of Medicine, St. Louis, 
Mo. Electronic address: akates@wustl.edu.

Cardiac amyloidosis (CA) results in symptoms of heart failure, atrial and 
ventricular arrhythmias, conduction disturbances, and profound autonomic 
dysfunction. These symptoms present unique management challenges as compared 
with patients without CA, and can be very debilitating. Thus, management of the 
cardiovascular symptoms of these patients plays a central role in their care. 
This review presents an overview of the typical cardiovascular manifestations 
encountered in patients with CA and highlights the key management considerations 
for each.

Copyright Â© 2022. Published by Elsevier Inc.

DOI: 10.1016/j.amjmed.2022.02.005
PMID: 35235819 [Indexed for MEDLINE]